Adoptive cell therapy with tumor-infiltrating lymphocytes for patients with metastatic ovarian cancer: A pilot study

被引：0
|
作者：
Pedersen, M. [1 ,2 ]
Westergaard, M. [1 ,2 ]
Nielsen, M. [1 ,2 ]
Borch, T. H. [1 ,2 ]
Poulsen, L. G. [3 ]
Hendel, H. [4 ]
Juhler-Nottrup, T. [5 ]
Met, O. [1 ,2 ]
Donia, M. [1 ,2 ]
Svane, I-M. [1 ,2 ]
机构：
[1] Herlev & Gentofte Hosp, Ctr Canc Immune Therapy, Dept Haematol, Herlev, Denmark
[2] Herlev & Gentofte Hosp, Dept Oncol, Herlev, Denmark
[3] Herlev & Gentofte Hosp, Dept Gynecol & Obstet, Herlev, Denmark
[4] Herlev & Gentofte Hosp, Dept Clin Physiol & Nucl Med, Herlev, Denmark
[5] Rigshosp, Dept Oncol, Copenhagen, Denmark
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1145PD
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Adoptive cell therapy with tumor-infiltrating lymphocytes supported by checkpoint inhibition across multiple solid cancer types
    Kverneland, Anders Handrup
    Chamberlain, Christopher Aled
    Borch, Troels Holz
    Nielsen, Morten
    Mork, Sofie Kirial
    Kjeldsen, Julie Westerlin
    Lorentzen, Cathrine Lund
    Jorgensen, Lise Pyndt
    Riis, Lene Buhl
    Yde, Christina Westmose
    Met, Ozcan
    Donia, Marco
    Marie Svane, Inge
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (10)
  • [42] The role of tumor-infiltrating lymphocytes in triple-negative breast cancer and the research progress of adoptive cell therapy
    Li, Ruonan
    Cao, Lili
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [43] Manipulating the Tumor Microenvironment Ex Vivo for Enhanced Expansion of Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy
    Chacon, Jessica Ann
    Sarnaik, Amod A.
    Chen, Jie Qing
    Creasy, Caitlin
    Kale, Charuta
    Robinson, John
    Weber, Jeffrey
    Hwu, Patrick
    Pilon-Thomas, Shari
    Radvanyi, Laszlo
    CLINICAL CANCER RESEARCH, 2015, 21 (03) : 611 - 621
  • [44] Adoptive T-Cell Therapy Using Autologous Tumor-Infiltrating Lymphocytes for Metastatic Melanoma Current Status and Future Outlook
    Wu, Richard
    Forget, Marie-Andree
    Chacon, Jessica
    Bernatchez, Chantale
    Haymaker, Cara
    Chen, Jie Qing
    Hwu, Patrick
    Radvanyi, Laszlo G.
    CANCER JOURNAL, 2012, 18 (02): : 160 - 175
  • [45] LTX-315 and adoptive cell therapy using tumor-infiltrating lymphocytes generate tumor specific T cells in patients with metastatic soft tissue sarcoma
    Nielsen, Morten
    Monberg, Tine
    Sundvold, Vibeke
    Albieri, Benedetta
    Hovgaard, Dorrit
    Petersen, Michael Mork
    Krarup-Hansen, Anders
    Met, Oezcan
    Camilio, Ketil
    Clancy, Trevor
    Stratford, Richard
    Sveinbjornsson, Baldur
    Rekdal, Oystein
    Junker, Niels
    Svane, Inge Marie
    ONCOIMMUNOLOGY, 2024, 13 (01):
  • [46] The prognostic value of tumor-infiltrating T lymphocytes in ovarian cancer
    Li, Jun
    Wang, Jieyu
    Chen, Ruifang
    Bai, Yang
    Lu, Xin
    ONCOTARGET, 2017, 8 (09) : 15621 - 15631
  • [47] Tumor-infiltrating lymphocytes in patients with metastatic melanoma receiving chemoimmunotherapy
    Hernberg, M
    Turunen, JP
    Muhonen, T
    Pyrhonen, S
    JOURNAL OF IMMUNOTHERAPY, 1997, 20 (06): : 488 - 495
  • [48] Prolonged disease-free period in patients with advanced epithelial ovarian cancer after adoptive transfer of tumor-infiltrating lymphocytes
    Fujita, K
    Ikarashi, H
    Takakuwa, K
    Kodama, S
    Tokunaga, A
    Takahashi, T
    Tanaka, K
    CLINICAL CANCER RESEARCH, 1995, 1 (05) : 501 - 507
  • [49] Adoptive cell therapy for patients with melanoma, using tumor-infiltrating lymphocytes genetically engineered to secrete interleukin-2
    Heemskerk, Bianca
    Liu, Ke
    Dudley, Mark. E.
    Johnson, Laura A.
    Kaiser, Andrew
    Downey, Stephanie
    Zheng, Zhili
    Shelton, Thomas E.
    Matsuda, Kant
    Robbins, Paul F.
    Morgan, Richard A.
    Rosenberg, Steven A.
    HUMAN GENE THERAPY, 2008, 19 (05) : 496 - 510
  • [50] Melanoma Clonal Heterogeneity Leads to Secondary Resistance after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes
    Konig, David
    Sandholzer, Michael T.
    Uzun, Sarp
    Zingg, Andreas
    Ritschard, Reto
    Thut, Helen
    Glatz, Katharina
    Kappos, Elisabeth A.
    Schaefer, Dirk J.
    Kettelhack, Christoph
    Passweg, Jakob R.
    Holbro, Andreas
    Baur, Katharina
    Medinger, Michael
    Buser, Andreas
    Lardinois, Didier
    Jeker, Lukas T.
    Khanna, Nina
    Stenner, Frank
    Kasenda, Benjamin
    Homicsko, Krisztian
    Matter, Matthias
    Mantuano, Natalia Rodrigues
    Zippelius, Alfred
    Laubli, Heinz
    CANCER IMMUNOLOGY RESEARCH, 2024, 12 (07) : 814 - 821
12345